Najib in stable condition, to continue treatment at HKL - Khairy

Khairy said he contacted HKL director Datin Paduka Dr Rohana Johan and was informed that Najib was in a stable condition and there was no need for him to be transferred to the National Heart Institute (IJN).

"I have requested HKL and Health deputy director-general (Medical) Datuk Dr Asmayani Khalib to provide Najib with the necessary follow-up treatment," he told a press conference after attending the Malaysia Book of Record Award presentation ceremony and the launch of the Record-Breaking COVID-19 Vaccination Report: Public Private Partnership here today.

Khairy said this in response to a statement by Najib's lawyer, Tan Sri Muhammad Shafee Abdullah, who was reported to have said that the former prime minister was likely to be transferred to the IJN and claimed that Najib exhibited fluctuating blood pressure.

On claims that Najib' was having high blood pressure because his medication was changed, Khary said it was not true.

He said Najib was given a generic high blood pressure medication by HKL, whose formula was the same as what the Pekan MP was taking previously.

"The medicines prescribed for Najib are the same as the ones he had taken before. The medicine is the same, the formula is the same, but in generic form," he added.

Yesterday, Health director-general Tan Sri Dr Noor Hisham Abdullah was reported to have said that Najib, was admitted to HKL on Sept 9 as an elective, non-emergency case to ensure his health was at "a good and optimum" level.

Najib was discharged the following day (Sept 10) after undergoing related examinations and tests by certified senior consultants, consisting of heads of clinical services in their respective fields.

However, yesterday, the High Court cut short Najib's hearing for misappropriation of RM2.3 billion in 1Malaysia Development Berhad (1MDB) funds to allow him to seek medical treatment.